文献速递炎症性肠病

欧洲前瞻性人群队列中克罗恩病十年病程:Epi-IBD研究

Long-Term Disease Course of Crohn's Disease in a Prospective European Population-Based Inception Cohort: An Epi-IBD Cohort Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-11-03

Epi-IBD队列纳入22个欧洲中心547例新诊断克罗恩病患者,前瞻性随访10年。西欧先进治疗使用率更高(42% vs 27%,P<.05)且启动更早(中位10 vs 46个月,P<.001),但手术率(24%,P=.9)、疾病进展(20%,P=.07)和住院率(41%,P=.5)东西欧无差异。先进治疗、诊断时狭窄/穿透型病变、疾病行为进展和既往吸烟与肠切除风险增加相关(均P<.05)。

要点

  • 西欧先进治疗使用率更高且启动更早,但10年手术率与东欧无差异。
  • 诊断时无并发症者10年内约1/5进展为复杂病变,1/4需手术。
  • 先进治疗、狭窄/穿透型病变、疾病行为进展及既往吸烟增加肠切除风险。

核心结论

  • 尽管西欧先进治疗使用更早更频繁,东西欧克罗恩病10年疾病结局无差异。
  • 诊断后10年,1/5诊断时无并发症患者进展为复杂病变,1/4需手术。

研究设计与样本

  • Epi-IBD为基于人群的前瞻性起始队列,纳入22个欧洲中心547例克罗恩病患者(东欧139例[25.4%],西欧408例[74.6%])。
  • 从诊断起前瞻性随访10年,统一收集数据;采用多变量Cox回归分析结局与协变量关联,并在倾向性评分匹配亚组中分析至首次肠切除时间。

主要发现

  • 10年先进治疗累积使用率西欧42%高于东欧27%(P<.05)。
  • 至启动先进治疗的中位时间西欧10个月短于东欧46个月(P<.001)。
  • 10年手术率东西欧相当,为24%(P=.9)。
  • 10年疾病从无并发症进展至复杂病变的比率为20%(P=.07),住院率为41%(P=.5)。
  • 先进治疗使用、诊断时狭窄或穿透型病变、疾病行为进展及既往吸烟均与肠切除风险增加相关(均P<.05)。

临床怎么用

  • 东西欧先进治疗策略差异未转化为10年手术或疾病进展结局差异,提示需结合疾病行为与吸烟等风险因素个体化决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The Epi-IBD cohort is a population-based inception cohort of patients with inflammatory bowel disease from 22 European centers. The aim was to assess the 10-year disease course of patients with Crohn's disease (CD) and how regional differences in treatment strategies impact the disease course. METHODS: Patients were followed prospectively from the time of diagnosis, with uniform collection data. Associations between outcomes and covariates were analyzed by multivariable Cox regressions in a propensity score-matched sub-population to address time to first intestinal resection. RESULTS: A total of 547 patients with CD were recruited (Eastern Europe: 139 [25.4%]; Western Europe: 408 [74.6%]). Ten-year cumulative rate of advanced therapy use was higher in Western (42%) compared with Eastern Europe (27%) (P < .05). The median period until initiation of advanced treatment was shorter in Western Europe (10 vs 46 months; P < .001). Despite these differences, the need for surgery remained comparable in Eastern and Western Europe, with a 10-year rate of 24% (P = .9). A similar comparability was observed for disease progression from uncomplicated disease to complicated disease (10-year rate: 20%; P = .07) and hospitalization (10-year rate: 41%; P = .5). Use of advanced therapy, stricturing or penetrating disease at diagnosis, progression of disease behavior, and former smoking were all associated with an increased risk of intestinal resection (all P < .05). CONCLUSIONS: Despite earlier and more frequent use of advanced therapies in Western Europe, no differences in disease outcomes were observed between Western and Eastern European patients. Ten years after diagnosis, 1 in 5 patients with uncomplicated disease at diagnosis progressed to complicated disease, and 1 in 4 needed surgery.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Wewer MD, Lophaven S, Lakatos PL, et al. Long-Term Disease Course of Crohn's Disease in a Prospective European Population-Based Inception Cohort: An Epi-IBD Cohort Study. Clin Gastroenterol Hepatol. 2025. PMID: 41192804. doi:10.1016/j.cgh.2025.10.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。